Roles of hepatic stellate cells in liver inflammation: a new perspective

[1]  K. Iwaisako,et al.  Hepatic stellate cells relay inflammation signaling from sinusoids to parenchyma in mouse models of immune‐mediated hepatitis , 2016, Hepatology.

[2]  J. Li,et al.  Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2 , 2016, Oncotarget.

[3]  D. Reddy,et al.  The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. , 2015, Journal of clinical and experimental hepatology.

[4]  N. Henderson,et al.  Hepatic stellate cells: central modulators of hepatic carcinogenesis , 2015, BMC Gastroenterology.

[5]  F. Tacke,et al.  The concanavalin A model of acute hepatitis in mice , 2015, Laboratory animals.

[6]  R. Weiskirchen,et al.  Lipopolysaccharide-induced inflammatory liver injury in mice , 2015, Laboratory animals.

[7]  R. Schwabe,et al.  Hepatic inflammation and fibrosis: Functional links and key pathways , 2015, Hepatology.

[8]  W. Thasler,et al.  Modulating CD4+ T Cell Migration in the Postischemic Liver: Hepatic Stellate Cells as New Therapeutic Target? , 2015, Transplantation.

[9]  Hao Wang,et al.  Adoptive transfer of hepatic stellate cells ameliorates liver ischemia reperfusion injury through enriching regulatory T cells. , 2014, International immunopharmacology.

[10]  C. Gandhi,et al.  A novel mouse model of depletion of stellate cells clarifies their role in ischemia/reperfusion- and endotoxin-induced acute liver injury. , 2014, Journal of hepatology.

[11]  Bixing Zhao,et al.  Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model , 2014, Laboratory Investigation.

[12]  C. Gandhi,et al.  The Transcriptomic Response of Rat Hepatic Stellate Cells to Endotoxin: Implications for Hepatic Inflammation and Immune Regulation , 2013, PloS one.

[13]  C. Peralta,et al.  Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. , 2013, Journal of hepatology.

[14]  P. Kubes,et al.  Immune surveillance by the liver , 2013, Nature Immunology.

[15]  G. Szabo,et al.  Immune and inflammatory pathways in NASH , 2013, Hepatology International.

[16]  Masahira Hattori,et al.  Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome , 2013, Nature.

[17]  Y. Shimizu,et al.  Hepatitis C Virus Infection Induces Inflammatory Cytokines and Chemokines Mediated by the Cross Talk between Hepatocytes and Stellate Cells , 2013, Journal of Virology.

[18]  S. Friedman,et al.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. , 2013, Gastroenterology.

[19]  Robert Pless,et al.  Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programs , 2012, Nature Immunology.

[20]  R. Bataller,et al.  Fueling fibrosis in chronic hepatitis C , 2012, Proceedings of the National Academy of Sciences.

[21]  E. Brunt,et al.  Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. , 2012, Journal of hepatology.

[22]  Wenxiu Zhao,et al.  The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma , 2012, International journal of oncology.

[23]  S. Thorgeirsson,et al.  Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. , 2012, Cancer research.

[24]  E. Seki,et al.  Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut , 2012, The Journal of physiology.

[25]  H. Lei,et al.  Endothelial cells are damaged by autophagic induction before hepatocytes in Con A-induced acute hepatitis. , 2010, International immunology.

[26]  Brigitte Vollmar,et al.  The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. , 2009, Physiological reviews.

[27]  F. Zoulim,et al.  Hepatitis C virus-induced hepatocarcinogenesis. , 2009, Journal of hepatology.

[28]  E. Robinet,et al.  Adaptive Immunity to Hepatitis C Virus , 2009, Viruses.

[29]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[30]  A. Bosserhoff,et al.  Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma , 2009, Cancer science.

[31]  R. Schwabe,et al.  Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[32]  Neil D Theise,et al.  Hepatic precancerous lesions and small hepatocellular carcinoma. , 2007, Gastroenterology clinics of North America.

[33]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[34]  J. Iredale,et al.  Impaired Proteolysis of Collagen I Inhibits Proliferation of Hepatic Stellate Cells , 2006, Journal of Biological Chemistry.

[35]  D. Brenner,et al.  Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .

[36]  D. Brenner,et al.  Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. , 2004, Gastroenterology.

[37]  M. Zabel,et al.  Expression of Cytokines (TNF-α, IL-1α, and IL-2) in Chronic Hepatitis C: Comparative Hybridocytochemical and Immunocytochemical Study in Children and Adult Patients , 2004 .

[38]  M. Karin,et al.  IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα , 2003 .

[39]  S. Milani,et al.  The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. , 2003, Gastroenterology.

[40]  Christian Jobin,et al.  Toll‐Like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells , 2003, Hepatology.

[41]  T. Thomas,et al.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension , 2002, Gut.

[42]  K. Boudjema,et al.  Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas , 2001, Hepatology.

[43]  C. Trautwein,et al.  TNF-α-Induced Expression of Adhesion Molecules in the Liver Is Under the Control of TNFR1—Relevance for Concanavalin A-Induced Hepatitis1 , 2001, The Journal of Immunology.

[44]  H. Fujiwara,et al.  Sublobular veins as the main site of lymphocyte adhesion/transmigration and adhesion molecule expression in the porto‐sinusoidal‐hepatic venous system during concanavalin A–induced hepatitis in mice , 2000, Hepatology.

[45]  G. Tiegs,et al.  Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins. , 1999, Toxicology.

[46]  Y. Iwakura,et al.  Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. , 1997, Journal of immunology.

[47]  G. Gerken,et al.  Role of sinusoidal endothelial cells of the liver in concanavalin A‐induced hepatic injury in mice , 1996, Hepatology.

[48]  H. Fujiwara,et al.  Critical involvement of interferon γ in the pathogenesis of T‐cell activation‐associated hepatitis and regulatory mechanisms of interleukin‐6 for the manifestations of hepatitis , 1996, Hepatology.

[49]  E. O’Neill,et al.  T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.

[50]  A. Wendel,et al.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.

[51]  M. Kutner,et al.  Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis , 1988, Hepatology.

[52]  J. Ladero,et al.  Liver fibrosis. , 2018, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[53]  R. Schwabe,et al.  TLR4 enhances TGF-beta signaling and hepatic fibrosis. , 2007, Nature medicine.

[54]  M. Zabel,et al.  Expression of cytokines (TNF-alpha, IL-1alpha, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patients. , 2004, Journal of Histochemistry and Cytochemistry.

[55]  M. Karin,et al.  IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. , 2003, Immunity.

[56]  G. Ramadori,et al.  Cytokines and the hepatic acute phase response , 1997, The Journal of pathology.